ZITL IS READY TO POP UP .....DO NOT SHORT HERE,,,,,,NO NO NO
ZITL HELD THE 24 S WELL....GOING TO 30 REAL SOON
--Finally, the latest in our exclusive coverage of hernias: The current issue of the New England Journal of Medicine published the results of an extensive Dutch study on hernia repair. Its conclusion: "Given the superior results of laparoscopic repair in terms of recovery and recurrence rates. . .a gradual introduction of laparoscopic hernia repair on a large scale seems warranted. . .''
If laparoscopic hernia repair ever replaces traditional surgery, the biggest benefactor, among public companies, could be Palo Alto-based General Surgical Innovations. Most of its sales currently come from a balloon-like device used to pry apart the insides of your abdomen during laparoscopic hernia surgery. The company went public a year ago at $15, but has since drifted down to its current price of $4.13; that's a slight premium to the $3.50 per share of cash in its coffers.
Investors are worried about a patent infringement lawsuit filed by a competitor, and the company's recent switch of distributors for the hernia product to Johnson & Johnson from U.S. Surgical. CEO Rod Young says the company is hoping that J&J will do a better job on its behalf.
Copyright 1997 San Francisco Chronicle. All rights reserved. The Bizinsider column cannot be reproduced, published, or redisseminated without the express prior written consent of Bizinsider. This includes reposting on any message board.
Transmitted: 5/28/97 6:37 AM (hhh |
